2-Aminobenzothiazole

2-Aminobenzothiazole 是一种 caspase 3/7 激活剂和抗癌细胞毒剂,还具有神经毒性,能通过激活 caspase 3/7 驱动凋亡 (apoptosis) 通路、诱导线粒体内膜去极化,并通过半胱天冬酶依赖通路触发早期和晚期凋亡,在斑马鱼模型中可诱导脑组织氧化损伤并抑制 GABA 和 5-HT 合成通路相关基因,长期暴露会影响其运动能力、社会行为、焦虑状态和认知功能,可用于人类喉癌及相关神经毒性研究。
产品编号: MS-A51724 纯度: 99.74% CAS No.: 136-95-8 分子式: C7H6N2S 分子量: 150.20
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
100g
询价
3-5 天
500g
询价
3-5 天
> 100g
询价
询价

产品描述

2-Aminobenzothiazole 是一种 caspase 3/7 激活剂和抗癌细胞毒剂,还具有神经毒性,能通过激活 caspase 3/7 驱动凋亡 (apoptosis) 通路、诱导线粒体内膜去极化,并通过半胱天冬酶依赖通路触发早期和晚期凋亡,在斑马鱼模型中可诱导脑组织氧化损伤并抑制 GABA 和 5-HT 合成通路相关基因,长期暴露会影响其运动能力、社会行为、焦虑状态和认知功能,可用于人类喉癌及相关神经毒性研究。

生物实验数据

生物活性 2-Aminobenzothiazole is a caspase 3/7 activator and anticancer cytotoxic agent that also exhibits neurotoxicity; it drives the apoptosis pathway by activating caspase 3/7, induces mitochondrial inner membrane depolarization, and triggers early and late apoptosis through a caspase-dependent pathway, induces oxidative damage in brain tissue and inhibits genes related to GABA and 5-HT synthesis pathways in zebrafish models, and long-term exposure affects locomotor ability, social behavior, anxiety status, and cognitive function, making it applicable to research on human laryngeal cancer and related neurotoxicity.
IC50 & Target

Caspase 3

 

Caspase-7

 

体外研究
(In Vitro)

2-aminobenzothiazole (3.125-100 μM; 24-72 h) 对人喉表皮样癌 (HEp-2) 细胞具有剂量依赖性细胞毒性,其 IC50 值分别为 5 μM (24 h)、27 μM (48 h) 和 5 μM (72 h)。
2-aminobenzothiazole (IC50; 24 h) 可诱导人喉表皮样癌 (HEp-2) 细胞发生凋亡,24 小时后有 42.62% 的细胞处于早期或晚期凋亡状态。
2-aminobenzothiazole (IC50; 24 h) 可激活人喉表皮样癌 (HEp-2) 细胞中的 Caspase 3/7。
2-Aminobenzothiazole 可抑制猪甲状腺过氧化物酶的活性,与其他苯并噻唑衍生物相比效力中等。

Cell Cytotoxicity Assay

Cell Line: human larynx epidermoid carcinoma (HEp-2) cells
Concentration: 3.125-100 μM (24 h); 3.13-100 μM (48 h); 3.13-100 μM (72 h)
Incubation Time: 24 h; 48 h; 72 h
Result: Caused a statistically significant (p < 0.05) decrease in HEp-2 cell viability at 3.125, 6.25, 12.5, 25, 50, 100 μM after 24 h incubation, with the highest growth inhibition at 100 μM, and an IC50 of 5 μM.
Caused a statistically significant (p < 0.05) decrease in HEp-2 cell viability at 6.25, 12.5, 25, 50, 100 μM after 48 h incubation, with the highest cytotoxicity at 100 μM, and an IC50 of 27 μM.
Induced a statistically significant (p < 0.05) viability reduction at 12.5, 25, 50, 100 μM after 72 h incubation, with the highest cytotoxicity at 100 μM, and an IC50 of 5 μM.
Exerted a dose-dependent cytotoxic effect across all incubation times.

Apoptosis Analysis

Cell Line: human larynx epidermoid carcinoma (HEp-2) cells
Concentration: IC50 concentration (24 h)
Incubation Time: 24 h
Result: Resulted in 56.93% of HEp-2 cells being alive, 25.99% in early apoptosis, 16.69% in late apoptosis, and 0.39% necrotic, with a total apoptotic cell percentage of 42.62% after 24-hour exposure.
体内研究
(In Vivo)

2-Aminobenzothiazole (5000 μg/L; 每日更新水体; 144 h) 会导致斑马鱼 (Danio rerio) 幼鱼于 144 hpf 时全部死亡。
2-Aminobenzothiazole (50-500 μg/L; 每 2 日更新水体; 120 dpf) 可在成年斑马鱼中诱导显著的神经行为缺陷 (运动能力下降、类焦虑行为、记忆受损)、脑氧化损伤以及 GABA 和 5-HT 通路基因表达失调。

Animal Model: Wild-type AB (adults, 120 days post-fertilization [dpf])
Dosage: 50 μg/L; 500 μg/L
Administration: aqueous exposure; water renewal every two days; 120 dpf
Result: Caused a significant 17.6% decrease in adult zebrafish body weight and 5.1% decrease in body length (500 μg/L, P < 0.05).
Showed no significant effect on adult zebrafish body weight or length (50 μg/L).
Significantly reduced adult zebrafish swimming velocity (50 and 500 μg/L, P < 0.05).
Significantly decreased entries into the center zone, increased distance between individuals, and reduced body contacts in adult zebrafish (500 μg/L, P < 0.05).
Significantly reduced time spent in the tank top and increased immobility time in the tank bottom in adult zebrafish (50 and 500 μg/L, P < 0.05).
Significantly reduced movement speed in the novel object area, decreased time spent in the novel object area, and increased time spent in the familiar object area in adult zebrafish (50 and 500 μg/L, P < 0.05).
Significantly increased brain tissue CAT and GSH enzyme activities, elevated MDA content, and inhibited SOD enzyme activity in adult zebrafish (50 and 500 μg/L, P < 0.05).
Significantly upregulated brain expression of oxidative stress-related genes (Cat, Mn-sod, nrf2, Cu/Zn-sod) in adult zebrafish (50 and 500 μg/L, P < 0.05).
Significantly suppressed expression of GABA synthesis pathway genes (gabrg2, gad2, gad1b, abat) and 5-HT synthesis pathway genes (tph2, tph1b, pet1, htr1aa) in adult zebrafish brain (50 and 500 μg/L, P < 0.05).
性状 固体
颜色 White to light yellow

化学信息

分子量 150.20
分子式 C7H6N2S
CAS No. 136-95-8

储存&溶解度

体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.00 mg/mL (13.32 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式

RT, protect from light

In solvent -80°C 1 year
-20°C 6 months
运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 100 mg/mL (665.73 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM6.6573 mL33.2867 mL66.5735 mL166.4337 mL
5 mM1.3315 mL6.6573 mL13.3147 mL33.2867 mL
10 mM0.6657 mL3.3287 mL6.6573 mL16.6434 mL
15 mM0.4438 mL2.2191 mL4.4382 mL11.0956 mL
20 mM0.3329 mL1.6643 mL3.3287 mL8.3217 mL
25 mM0.2663 mL1.3315 mL2.6629 mL6.6573 mL
30 mM0.2219 mL1.1096 mL2.2191 mL5.5478 mL
40 mM0.1664 mL0.8322 mL1.6643 mL4.1608 mL
50 mM0.1331 mL0.6657 mL1.3315 mL3.3287 mL
60 mM0.1110 mL0.5548 mL1.1096 mL2.7739 mL
80 mM0.0832 mL0.4161 mL0.8322 mL2.0804 mL
100 mM0.0666 mL0.3329 mL0.6657 mL1.6643 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 1 year; -20°C, 6 months。-80°C储存时,请在1年内使用, -20°C储存时,请在6个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础